SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-14-001485
Filing Date
2014-03-31
Accepted
2014-03-31 10:31:48
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tbuff_10k.htm 10-K 1678944
2 CERTIFICATION tbuff_ex311.htm EX-31.1 13085
3 CERTIFICATION tbuff_ex312.htm EX-31.2 13294
4 CERTIFICATION tbuff_ex321.htm EX-32.1 7205
5 CERTIFICATION tbuff_ex322.htm EX-32.2 7668
6 img002.jpg GRAPHIC 15603
7 img001.jpg GRAPHIC 15603
8 auditrpt.jpg GRAPHIC 185968
  Complete submission text file 0001354488-14-001485.txt   6523648

Data Files

Seq Description Document Type Size
9 tbuff-20131231.xml EX-101.INS 741734
10 tbuff-20131231.xsd EX-101.SCH 60923
11 tbuff-20131231_cal.xml EX-101.CAL 63888
12 tbuff-20131231_def.xml EX-101.DEF 86670
13 tbuff-20131231_lab.xml EX-101.LAB 333961
14 tbuff-20131231_pre.xml EX-101.PRE 236977
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31198 | Film No.: 14728222
SIC: 2834 Pharmaceutical Preparations